Monday, July 13th Edition
Cory Ohlendorf
Compiled and written by
CORY OHLENDORF
Valet. Editor

Today’s Big Story

Americans on GLP-1s Surge

 

And while some Medicare beneficiaries eligible, most healthcare plans don’t cover them

 

If you’ve been paying attention, this probably won’t be shocking news. But GLP-1 drugs are more popular than ever. Late last week, Gallup announced that more than 11% of U.S. adults are currently taking the new medications for weight loss, which is a huge jump from the 3% who said they were using the drugs in 2024. And 15% of those polled said they’ve used the drugs at some point, which is an increase of 9 percentage points.

And according to PBS News, that number could climb even higher as Medicare has cleared the way for some patients to access the drugs. Starting this month, some Medicare beneficiaries can buy these popular weight loss drugs for only $50 a month. Of course, that’s a massive discount from retail prices. It’s part of a new temporary pilot program to give millions of Americans access to the drugs that many have been unable to afford. (The program is scheduled to run through the end of 2027.)

However, most consumers will have to wait for broader insurance coverage of GLP-1s until prices come down and clear evidence emerges that they will reduce health care costs, the CEO of CVS Health (which includes Aetna insurance), said in a recent interview. “Everybody intuitively believes these medications create long-term health benefits, but the evidence hasn’t yet demonstrated that paying today’s prices generates enough downstream savings,” he said. “The economics simply aren’t there yet.”

What does that mean, exactly? Well, there is no dispute that helping people lose weight reduces cholesterol, blood pressure and improves heart health. But the return on investment of covering the drugs—in terms of reduced costly medical procedures and hospitalizations—has not yet been proved.

And while pills are latest iteration of the drug, instead of regular injections with a needle, a tiny GLP-1 implant is the latest bet to help patients maintain their weight loss. Just beware of “Ozempic feet”, the latest side effect being talked about.

 
FYI:

Eli Lilly’s tirzepatide (marketed as Mounjaro for type 2 diabetes and Zepbound for obesity) became the world's best-selling drug late last year.

Iran Launches Attacks on Gulf States

 

They also announced the closure of the Strait of Hormuz, but U.S. officials rejected the claim

This isn’t letting up. American allies in the Persian Gulf reported new attacks by Iran early Monday morning as Tehran announced another round of retaliatory strikes against U.S. military sites. It basically extends the pattern of hostilities by both sides as the ceasefire continues to unravel.

The U.S. military shot down an Iranian cruise missile and one-way attack drone, Capt. Tim Hawkins, a spokesman for U.S. Central Command, told the Washington Post. In a post on X, CENTCOM said the U.S. military carried out more strikes against Iran at 5 p.m. Eastern time on Sunday to degrade their ability to attack commercial vessels crossing the Strait.

The strikes followed a statement by the Islamic Revolutionary Guard Corps carried on state media that said the strait was considered closed until further notice. The IRGC accused the U.S. of interfering in the waterway. U.S. officials, including President Donald Trump, rejected Tehran’s claim of control over the strait— continuing a cycle of contradictory statements and a stalemate.

 
FYI:

Brent crude, the international oil benchmark, rose nearly 5% early Monday, to $79 a barrel. That is up more than 9% higher than its prewar price.

Jannik Sinner Defends His Wimbledon Title

 

And Linda Noskova recovered from 2nd-set meltdown to win

In a tight final, Jannik Sinner had a chance to break opponent Alexander Zverev’s serve. He fell to the ground mid-rally, picked himself back up and forced an error out of Zverev to clinch the first break of serve almost three hours into the match. The Italian world number one would again drop to the ground—but this time in celebration after completing a four-set comeback victory to become only the 10th man in the Open era to retain the Wimbledon men’s singles title.

The women’s final was pretty intense, too. Linda Nosková defeated Karolína Muchová in three sets 6-2, 5-7, 6-3 to claim her first Grand Slam women’s singles title in the all-Czech Republic final on Saturday. After dominating the opening set 6-2 and leading in the second, the No. 9 seed Nosková saw five championship points slip away as No. 10 seed Muchová put on a stunning comeback clinic to steal the set 7-5. However, the 21-year-old Noskova regrouped in the decider to weather the storm and capture the title in her first major final appearance. (And became the third Czech woman in four years to win the grass-court major.)

Prince William joined his wife Kate and two of their children for the men’s final Sunday in a star-studded Royal Box that also included actors Dustin Hoffman, Nicole Kidman and Ben Stiller. Kate is the patron of the All England Club and presented the trophy to both Sinner and Noskova.

 
Meanwhile:

Sacha Baron Cohen’s Ali G showed up to the match as well (apparently there’s a new film coming soon).

Have you
heard about ...

 
 
 
 
 
 

🔒

Today’s Member Extras

Valet. Member

Exclusive

 

Health & Fitness Debriefing

The Trends You Need to Know About Right Now

 

What to know about the Cyclosporiasis outbreak and how to lower your LDL cholesterol.

 

Today on

 

From sweat-wicking fabrics to athletic fits that flatter, these are the workout shirts that outperform the rest.

 
 

From a rugged pair of hybrid shorts to an summer-weight cropped henley.

 
Tip of the Day:

Body acne spikes in summer heat, but benzoyl peroxide body wash kills the bacteria causing those confidence-crushing breakouts on your back and chest.

Morning Motto

Everything is a lesson.

 

Follow: @poetstribe

Keep Reading